Liposomalization of SN-38 as active metabolite of CPT-11

Journal of Controlled Release

Volumn 108, Issue 2-3, 2005, Pages 453-459

  Sadzuka, Yasuyuki ^a   Takabe, Hiroyuki ^a   Sonobe, Takashi ^a  

^a UNIVERSITY OF SHIZUOKA   (Japan)

Author keywords

CPT 11; Film loading method; Liposome; SN 38

Indexed keywords

CELLS; CHEMOTHERAPY; DRUG DOSAGE; FREEZING; METABOLITES; TUMORS;

CPT-11; FILM LOADING METHOD; LIPOSOMES; SN-38;

DISEASE CONTROL;

7 ETHYL 10 HYDROXYCAMPTOTHECIN; DRUG METABOLITE; IRINOTECAN;

ARTICLE; DRUG SOLUBILITY; FILM; FREEZE DRYING; FREEZING; HYDROPHOBICITY; PRIORITY JOURNAL; THAWING;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CAMPTOTHECIN; DRUG CARRIERS; DRUG COMPOUNDING; EXCIPIENTS; FREEZE DRYING; FREEZING; LIPOSOMES; PRODRUGS;

EID: 27744580052     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2005.08.023     Document Type: Article

References (43)

1. A. Samah, L. Michael, L. Claus-M, B. Udo, and E. Carsten Assessing transferrin modification of liposomes by atomic force microscopy and transmission electron microscopy Eur. J. Pharm. and Biopharm. 60 2005 295 303
2. S.A. Abraham, D.N. Waterhouse, L.D. Mayer, P.R. Cullis, T.D. Madden, and M.B. Bally The liposomal formulation of doxorubicin Methods Enzymol. 391 2005 71 97
3. O. Shuichi, and N. Kazuhiro Effects of complexation between liposome and poly (malic acid) on aggregation and leakage behaviour Biomaterials 21 2000 867 876
4. W.W. Sułkowski, D. Pentak, K. Nowak, and A. Sułkowska The influence of temperature cholesterol content and pH on liposome stability J. Mol. Struct. 3 2005 737 747
5. S.P. Vyas, S. Quraishi, S. Gupta, and K.S. Jaganathan Aerosolized liposome-based delivery of amphotericin B to alveolar macrophages Int. J. Pharm. 296 2005 12 25
6. H. Iinuma, K. Maruyama, K. Okinaga, K. Sasaki, T. Sekine, O. Ishida, N. Ogiwara, K. Johkura, and Y. Yonemura Intracellular targeting therapy of cisplatin-encapsulated transferring-polyethylene glycol liposome on peritoneal dissemination of gastric cancer Int. J. Cancer 99 2002 130 137
7. V.V. Ranade Drug delivery system. 1 Site-specific drug delivery using liposomes as carriers J. Clin. Pharmacol. 29 1989 685 694
8. G. Gregoriadis Liposomes as a drug delivery system: optimization studies Adv. Exp. Med. Biol. 238 1988 151 159
9. R.L. Juliano Liposomes as drug carriers in the therapy of infectious diseases Horiz. Biochem. Biophys. 9 1989 249 279
10. I.J. Fidler The use of liposomes as drug carriers in the immunotherapy of cancer Horiz. Biochem. Biophys. 9 1989 213 248
11. R.J. Hong, and Y.L. Tseng Phase I and pharmacokinetic study of a stable, polyethylene-glycolated liposomal doxorubicin in partients with solid tumors Cancer 91 2001 1826 1833
12. Y.M. Rustem, C. Dave, E. Mayhew, and D. Papahadjopoulos Role of liposome type and route of administration in the antitumor activity of liposome-entrapped 1-bate-d-arabinofuranosylcytosine against mouse L1210 leukemia Cancer Res. 39 1979 1390 1395
13. R.M. Abra, C.A. Hunt, and D.T. Lau Liposome disposition in vivo J. Pharm. Sci. 73 1984 203 206
14. N. Oku, K. Doi, Y. Namba, and S. Okada Therapeutic effect of adriamycin encapsulated in long-circulating liposomes on Meth-A-sarcoma-bearing mice Int. J. Cancer 58 1994 415 419
15. N. Oku, T. Toyota, S. Shuto, A. Sakai, H. Itoh, and S. Okada Therapeutic effect of reticuloendothelial system (RES)-avoiding liposomes containing a phospholipid analogue of 5-fluorouracil, dipalmitoylphosphatidylfluorouridine, in Meth A sarcoma-bearing mice Biol. Pharm. Bull. 17 1994 1414 1416
16. Y. Tokudome, N. Oku, K. Doi, Y. Namba, and S. Okada Antitumor activity of vincristin encapsulated in glucuronide-modified long-circulating liposomes in mice bearing Meth A sarcoma Biochim. Biophys. Acta 1279 1996 70 74
17. G.L. Berestein, L. Kasi, M.G. Rosemblum, T. Haynie, M. Jahns, H. Glenn, R. Mehta, G.M. Mavlight, and E.M. Hersh Distribution and pharmacology of intravenous technetium-99-m-labeled multilamellar liposomes in rats and mice Cancer Res. 44 1984 375 378
18. K. Shimada, A. Miyagishima, Y. Sadzuka, Y. Nozawa, and S. Hirota Determination of the thickness of fixed aqueous layer around the polyethleneglycol-coated liposomes J. Drug Target. 3 1995 283 289
19. N. Oku, and Y. Namba Long-circulating liposomes Crit. Rev. Ther. Drug Carr. Syst. 11 1994 231 270
20. D. Needham, T.J. McIntosh, and D.D. Lasic Repulsive interactions and mechanical stability of polymer-grafted lipid membranes Biochim. Biophys. Acta 1108 1992 40 48
21. A.L. Klibanov, K. Maruyama, A.M. Beckerleg, V.P. Torchilin, and L. Huang Activity of amphipathic poly(ethylene glycol)5000 to prolong the circulation time of the liposomes depends on the liposome size and is unfavorable for immunoliposome binding to target Ibid 1062 1991 142 148
22. T. Yuda, Y. Pongpaibul, K. Maruyama, and M. Iwatatsuru Activity of amphipathic polyethylene glycol prolong the circulation time of liposomes J. Pharm. Sci. Jpn. 59 1999 32 42
23. C. Tilcock, P. Cullis, T. Dempsey, B.N. Youenns, and D. Fisher Aqueous two-phase polymer partitioning of lipid vesicles of defined size and composition Biochem. Biophys. Acta 979 1989 208 214
24. J. Senior, C. Delgado, D. Fisher, C. Tilcock, and G. Gregoriadis Influence of surface hydrophilicity of liposomes on their interaction with plasma protein and clearace from the circulation: studies with poly(ethylene glycol)-corted vesicle Ibid 1062 1991 77 82
25. T.L. Kuhi, D.E. Leckband, D.D. Lasic, and J.N. Israelachvili Modulation of interaction forces between bilayers exposing short-chained ethylene oxid headgroups Biophys. J. 66 1994 1479 1488
26. V.P. Torchilin, V.G. Omelyanenko, M.I. Papisov, A.A. Bogdanov, V.S. Trubetsloy, J.N. Herron, and C.A. Gentry Poly(ethylene glycol) on the liposome surface: on the mechanism of polymer-coated liposome longevity Biochem. Biophys. Acta 1195 1994 11 20
27. J. Janzen, X. Song, and D.E. Brooks Interfacial thickness of liposomes containing poly(ethylene glycol)-cholesterol from electrophoresis Biophys. J. 70 1996 313 320
28. Y. Kawato, M. Aoyama, Y. Hirota, H. Kuga, and K. Sato Intracellular roles of SN-38, a metabolite of the camptothecin derivative CPT-11, in the antitumor effect of CPT-11 Cancer Res. 51 1991 4187 4191
29. Y. Kawato, T. Furuta, M. Aonuma, T. Yokokura, and K. Matsumoto Antitumor activity of a camptothecin derivative, CPT-11, against human tumor xenografts in nude mice Cancer Chemother. Pharmacol. 28 1991 192 198
30. S. Kudoh, M. Takada, N. Masuda, K. Nakagawa, and K. Itoh Enhanced antitumor efficacy of a combination of CPT-11, a new derivative of camptothecin, and cisplatin against human jung tumor xenografts Jpn. J. Cancer Res. 84 1993 203 207
31. G. Nishimura, T. Satou, Y. Yoshimitsu, Y. Kurosaka, and T. Fujimura Effect of chemotherapy using irinotecan (CPT-11) against recurrent colorectal cancer Jpn. J. Cancer Chemother. 27 1995 93 97
32. M. Nishio, F. Ohyanagi, F. Taguch, M. Matsuda, Y. Sato, S. Okumura, K. Nakagawa, and T. Horai Phase I study of combination chemotherapy with gemcitabine and irinotecan for non-small cell lung cancer Lung Cancer 48 2005 115 119
33. Y. Kawato, M. Aonuma, K. Matsumoto, and K. Sato Production of SN-38, a main metabolite of the camptothecin derivative CPT-11, and its species and tissue specificities Xenobiotic Metab. Dispos. 6 1991 899 907
34. A. Kono, and Y. Hara Conversion of CPT-11 into SN-38 in human tissues Jpn. J. Cancer Chemother. 18 1991 2175 2178
35. K. Ohtsuka, S. Inoue, M. Kameyama, A. Kanetosi, T. Fujimoto, K. Takaoka, Y. Araya, and A. Shida Intracellular conversion of irinotecan to its active form, SN-38, by native carboxylesterase in human non-small cell lung cancer Lung Cancer 41 2003 187 198
36. M.H. Wu, B. Yan, R. Humerickhouse, and M.E. Dolan Irinotecan activation by human carboxylesterases in colorectal adenocarcinoma cells Clin. Cancer Res. 8 2002 2696 2700
37. R. Humerickhouse, K. Lohrbach, L. Li, W.F. Bosron, and M.E. Dolan Characterization of CPT-11 hydrolysis by human liver carboxylesterase isoforms hCE-1 and hCE-2 Cancer Res. 60 2000 1189 1192
38. K. Ohtsuka, S. Inoue, M. Kameyama, A. Kanetoshi, T. Fujimoto, K. Takaoka, Y. Araya, and A. Shida Intracellular conversion of irinotecan to its active form, SN-38, by native carboxylesterase in human non-small cell lung cancer Lung Cancer 41 2003 187 198
39. Y. Sadzuka, S. Hirotsu, and S. Hirota Effect of liposomalization on the antitumor activity, side-effects and tissue distribution of CPT-11 Cancer Lett. 127 1998 99 106
40. J.A. Zhang, T. Xuan, M. Parmar, L. Ma, S. Ugwu, S. Ali, and I. Ahmad Development and characterization of a novel liposome-based formulation of SN-38 Int. J. Pharm. 270 2004 93 107
41. A.D. Bangham, M.M. Standish, and J.C. Watkins Diffusion of univalent ions across the lamellae of swollen phospholipids J. Mol. Biol. 13 1965 238 252
42. N. Oku, D.A. Kendall, and R.C. MacDonald A simple procedure for the determination of the trapped volume of liposomes Biochim. Biophys. Acta 691 1982 332 340
43. R.L. Shew, and D.W. Deamer A novel method for encapsulation of macromolecules in liposomes Biochim. Biophys. Acta 816 1985 1 8